drugset / Trial / NCT00532467
Multiple Dose Safety Study of SRX251 Capsules in Healthy Volunteers
RandomizedSingle-groupQuadruple-blindTreatment
Summary
This study is the second study to evaluate SRX251 in healthy volunteers and it represents the first multiple dose study. The primary objective of this study is to evaluate the safety and tolerability of escalating multiple oral doses of SRX251 capsules for 5 days in healthy adult volunteers. Levels of the drug in blood plasma will also be determined.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-02
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SRX251 | Unknown | — | Oral |
Indications
No indication recorded.